This invention is directed towards novel alkylamide derivatives as
bradykinin receptor antagonists useful for the treatment of bradykinin
modulated disorders such as pain, inflammation, asthma and allergy.
Furthermore, the present invention is directed to novel alkylamide
derivatives as bradykinin receptor agonists useful for the treatment of
bradykinin modulated disorders such as hypertension and the like.